Rhythm Pharmaceuticals Inc. – RYTM: SEC Investigation Update
Added to Watch List of companies with confirmed, undisclosed SEC investigations. This is Rhythm’s first appearance on our Watch List since we started covering the company in May-2020.
Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC. Our work is heavily reliant on company disclosures and our expertise in using the Freedom of Information Act.
To access the full SEC Investigation Update report we published on this company (only visible when logged-in).